Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: Caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI)
Cid, Joan, Pérez-Valencia, Amanda Isabel, Torrente, Miguel Ãngel, Ãvarez-Larrán, Alberto, DÃaz-Ricart, Maribel, Esteve, Jordi, Lozano, MiquelJournal:
Transfusion and Apheresis Science
DOI:
10.1016/j.transci.2020.103011
Date:
November, 2020
File:
PDF, 68 KB
2020
File converter
More search results
More benefits 
